Two of the four patients with PD-L1 positive chordoma achieved CR or PR according to RECIST, including one patient who experienced a clear tumor bulk reduction and clinical improvement for six months, and the other patient who achieved CR at lung metastases for more than two years [28,32,34,35]. This evidence concerns the gene CD274 and neoplasm.